Asciminib and inotuzumab ozogamicin: a new combination for highly refractory Ph-positive B-cell acute lymphoblastic
Aneta Strumilowska1, Katherine Devitt2, Joanna Conant2
1Department of Medicine, Division of Hematology and Oncology, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Leukemia Research Reports
|October 2, 2025
Abstract
No abstract available in PubMed .


